enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Alternating electric field therapy - Wikipedia

   en.wikipedia.org/wiki/Alternating_electric_field...

   A clinical TTFields device is manufactured by Novocure under the trade name Optune (formerly NovoTTF-100A), and is approved in the United States, Japan, Israel and multiple countries in Europe for the treatment of recurrent glioblastoma. These devices generate electromagnetic waves between 100 and 300 kHz. The devices can be used in conjunction ...

3. FDA Approves NovoCure's Portable Device Producing Tumor ... - AOL

   www.aol.com/fda-approves-novocures-portable...

   On Tuesday, the FDA approved NovoCure’s (NASDAQ:NVCR) Optune Lua for concurrent use with PD-1/PD-L1 inhibitors or docetaxel for adult patients with metastatic non-small cell lung cancer (mNSCLC ...

4. Novocure's device shown to slow cancer progression in the ...

   www.aol.com/news/novocures-lung-cancer-device...

   The device, branded as Optune Gio and Optune Lua, brought in $509 million in revenue last year. Secondary tumors in the brain, called brain metastases, affect about 25% of patients with NSCLC.

5. Novocure Has Already Doubled in 2024. Can It Soar ... - AOL

   www.aol.com/finance/novocure-already-doubled...

   Novocure's devices apply an electric field that interferes with cell division. Tumor treating fields won't destroy a tumor singlehandedly but can slow down their growth rate. ... If Optune Lua and ...

6. NovoCure (NVCR) Q3 2024 Earnings Call Transcript - AOL

   www.aol.com/novocure-nvcr-q3-2024-earnings...

   NovoCure (NASDAQ: NVCR) Q3 2024 Earnings Call ... But with the recent approval of Optune Lua for non-small cell lung cancer, we are launching our next large indication. ... Breakthrough device ...

7. Responsive neurostimulation device - Wikipedia

   en.wikipedia.org/wiki/Responsive_neuro...

   Responsive neurostimulation device is a medical device that senses changes in a person's body and uses neurostimulation to respond in the treatment of disease. The FDA has approved devices for use in the United States in the treatment of epileptic seizures [ 1 ] and chronic pain [ 2 ] conditions.

8. AutoPulse - Wikipedia

   en.wikipedia.org/wiki/AutoPulse

   The AutoPulse is an automated, portable, battery-powered cardiopulmonary resuscitation device created by Revivant and subsequently purchased and currently manufactured by ZOLL Medical Corporation. It is a chest compression device composed of a constricting band and half backboard that is intended to be used as an adjunct to CPR during advanced ...

9. NovoCure's Tumor-Treating Electric Fields Shows Promise In ...

   www.aol.com/finance/novocures-tumor-treating...

   Also Read: FDA Approves NovoCure’s Portable Device Producing Tumor-Treating Electric Fields For Previously Treated Lung Cancer Patients. In the intent-to-treat population, ...